Melatonin Treatment in Children with Developmental Disabilities

  • A.J. Schwichtenberg
    Correspondence
    Corresponding author. Department of Human Development and Family Studies, 1202 West State Street, West Lafayette, IN 47907-2055.
    Affiliations
    Department of Human Development and Family Studies, Department of Psychological Sciences, Department of Speech, Language, and Hearing Sciences, Purdue University, 1202 West State Street, West Lafayette, IN 47907-2055, USA
    Search for articles by this author
  • Beth A. Malow
    Affiliations
    Sleep Disorders Division, Department of Neurology, Vanderbilt University Medical Center, 1161 21st Avenue South, Room A-0116, Nashville, TN 37232-2551, USA
    Search for articles by this author
Published:March 24, 2015DOI:https://doi.org/10.1016/j.jsmc.2015.02.008

      Keywords

      To read this article in full you will need to make a payment

      Purchase one-time access:

      Academic & Personal: 24 hour online accessCorporate R&D Professionals: 24 hour online access
      One-time access price info
      • For academic or personal research use, select 'Academic and Personal'
      • For corporate R&D use, select 'Corporate R&D Professionals'

      Subscribe:

      Subscribe to Sleep Medicine Clinics
      Already a print subscriber? Claim online access
      Already an online subscriber? Sign in
      Institutional Access: Sign in to ScienceDirect

      References

        • Owens J.
        • Rosen C.
        • Mindell J.
        • et al.
        Use of pharmacotherapy for insomnia in child psychiatry practice: a National Survey.
        Sleep Med. 2010; 11: 692-700
        • Guénolé F.
        • Baleyte J.M.
        Effects of melatonin should be studies separately in each neurodevelopmental disorder and with specific sleep diagnoses.
        Pediatr Neurol. 2012; 46: 60-61
        • Braam W.
        • Didden R.
        • Smits M.
        • et al.
        Melatonin treatment in individuals with intellectual disability and chronic insomnia: a randomized placebo-controlled study.
        J Intellect Disabil Res. 2008; 52: 256-264
        • Coppola G.
        • Iervolino G.
        • Mastrosimone M.
        • et al.
        Melatonin in wake- sleep disorders in children, adolescents, and young adults with mental retardation with or without epilepsy: a double-blind, cross-over, placebo-controlled trial.
        Brain Dev. 2004; 26: 373-376
        • Dodge N.
        • Wilson A.G.
        Melatonin for treatment of sleep disorders in children with developmental disabilities.
        J Child Neurol. 2001; 16: 581-584
        • Wasdell M.
        • Jan J.
        • Bomben M.
        • et al.
        A randomized, placebo-controlled trail of controlled release melatonin treatment of delayed sleep phase syndrome and impaired sleep maintenance in children with neurodevelopmental disabilities.
        J Pineal Res. 2008; 4: 57-64
        • De Leersnyder H.
        • de Blois M.
        • Vekemans M.
        • et al.
        β1-adrenergic antagonists improve sleep and behavioural disturbances in a circadian disorder, Smith-Magenis syndrome.
        J Med Genet. 2001; 38: 586-590
        • Gringras P.
        • Gamble C.
        • Jones A.P.
        • et al.
        Melatonin for sleep problems in children with neurodevelopmental disorders: randomised double masked placebo controlled trial.
        Br Med J. 2012; 345: e6664
        • De Leersnyder H.
        • Zisapel N.
        • Laudon M.
        Prolonged-release melatonin for children with neurodevelopmental disorders.
        Pediatr Neurol. 2011; 45: 23-26
        • Camfield P.
        • Gordon K.
        • Dooley J.
        • et al.
        Melatonin appears ineffective in children with intellectual deficits and fragmented sleep: six “N of 1” trials.
        J Child Neurol. 1996; 11: 341-343
        • Sheldon H.
        Pro-convulsant effects of oral melatonin in neurologically disabled children.
        Lancet. 1998; 351: 1254
        • Butler M.
        • Brandau D.
        • Theodoro M.
        • et al.
        Morning melatonin levels in Prader- Willi syndrome.
        Am J Med Genet. 2009; 149A: 1809-1813
        • Guerroro J.
        • Pozo D.
        • Diaz-Rodriguez J.
        • et al.
        Impairment of the melatonin rhythm in children with Sanfilippo syndrome.
        J Pineal Res. 2006; 40 ([Letter to the Editor]): 192-193
        • Tamarkin L.
        • Abastillas P.
        • Chen H.C.
        • et al.
        The daily profile of plasma melatonin in obese and Prader-Willi syndrome children.
        J Clin Endocrinol Metab. 1982; 55: 491-495
        • Uberos J.
        • Romero J.
        • Molina-Carballo A.
        • et al.
        Melatonin and elimination of kynurenines in children with Down’s syndrome.
        J Pediatr Endocrinol Metab. 2010; 23: 277-282
        • Doyen C.
        • Mighiu D.
        • Kaye K.
        • et al.
        Melatonin in children with autistic spectrum disorders: recent and practical data.
        Eur Child Adolesc Psychiatry. 2011; 20: 231-239
        • Guénolé F.
        • Godbout R.
        • Nicolas A.
        • et al.
        Melatonin for disordered sleep in individuals with autism spectrum disorders: systematic review and discussion.
        Sleep Med Rev. 2011; 15: 379-387
        • Rossignol D.
        • Frye R.
        Melatonin in autism spectrum disorders: a systemic review and meta-analysis.
        Dev Med Child Neurol. 2011; 53: 783-792
        • Andersen M.I.
        • Kaczmarska J.
        • McGrew G.S.
        • et al.
        Melatonin for insomnia in children with autism spectrum disorders.
        J Child Neurol. 2008; 23: 482-485
        • Gupta R.
        • Hutchins J.
        Melatonin: a panacea for desperate parents? (Hype or truth).
        Arch Dis Child. 2005; 90: 986-987
        • Paavonen E.J.
        • Nieminen-von Went T.
        • Vanhala R.
        • et al.
        Effectiveness of melatonin in the treatment of sleep disturbances in children with Asperger disorder.
        J Child Adolesc Psychopharmacol. 2003; 13: 83-95
        • Giannotti F.
        • Cortesi F.
        • Cerquiglini A.
        • et al.
        An open-label study of controlled release melatonin in treatment of sleep disorders in children with autism.
        J Autism Dev Disord. 2006; 36: 741-752
        • Malow B.
        • Adkins K.
        • McGrew S.
        • et al.
        Melatonin for sleep in children with autism: a controlled trail examining dose, tolerability, and outcomes.
        J Autism Dev Disord. 2012; 42: 1729-1737
        • Garstang J.
        • Wallis M.
        Randomized controlled of melatonin for children with autistic spectrum disorders and sleep problems.
        Child Care Health Dev. 2006; 32: 585-589
        • Wirojanan J.
        • Jacquemont S.
        • Siaz R.
        • et al.
        The efficacy of melatonin for sleep problems in children with autism, fragile X syndrome or autism and fragile X syndrome.
        J Clin Sleep Med. 2009; 5: 145-150
        • Wright B.
        • Sims D.
        • Smart S.
        • et al.
        Melatonin versus placebo in children with autism spectrum conditions and severe sleep problems not amenable to behavior management strategies: a randomized controlled crossover trial.
        J Autism Dev Disord. 2011; 41: 175-184
        • Cortesi F.
        • Giannotti F.
        • Sebastiani T.
        • et al.
        Controlled-release melatonin, singly and combined with cognitive behavioural therapy, for persistent insomnia in children with autism spectrum disorders: a randomized placebo-controlled trial.
        J Sleep Res. 2012; 21: 700-709
        • McArthur A.J.
        • Budden S.S.
        Sleep dysfunction in Rett syndrome: a trial of exogenous melatonin treatment.
        Dev Med Child Neurol. 1998; 40: 186-192
        • Hancock E.
        • O’Callaghan F.
        • Osborne J.
        Effect of melatonin dosage on sleep disorder in tuberous sclerosis complex.
        J Child Neurol. 2005; 20: 78-80
        • O’Callaghan J.F.
        • Clarke A.A.
        • Hancoack E.
        • et al.
        Use of melatonin to treat sleep disorders in tuberous sclerosis.
        Dev Med Child Neurol. 1999; 41: 123-126
        • Kulman G.
        • Lissoni P.
        • Rovelli F.
        • et al.
        Evidence of pineal endocrine hypofunction in autistic children.
        Neuro Endocrinol Lett. 2000; 21: 31-34
        • Melke J.
        • Goubran Botros H.
        • Chaste P.
        • et al.
        Abnormal melatonin synthesis in autism spectrum disorders.
        Mol Psychiatry. 2008; 13: 90-98
        • Tordjman S.
        • Anderson G.M.
        • Pichard N.
        • et al.
        Nocturnal excretion of 6-sulphatoxymelatonin in children and adolescents with autistic disorder.
        Biol Psychiatry. 2005; 57: 134-138
        • Goldman S.
        • Adkins K.
        • Wade Calcutt M.
        • et al.
        Melatonin in children with autism spectrum disorders: endogenous and pharmacokinetic profiles in relation to sleep.
        J Autism Dev Disord. 2014; 44: 2525-2535
        • Potocki L.
        • Glaze D.
        • Tan D.
        • et al.
        Circadian rhythm abnormalities of melatonin in Smith-Magenis syndrome.
        J Med Genet. 2000; 37: 428-433
        • Carpizo R.
        • Martinez A.
        • Mediavilla D.
        • et al.
        Smith-Magenis syndrome: a case report of improved sleep after treatment with β1-adrenergic antagonists and melatonin.
        J Pediatr. 2006; 149: 409-411
        • Chou I.
        • Tsai F.
        • Yu M.
        • et al.
        Smith Magenis syndrome with bilateral vesicoureteral reflux: a case report.
        J Formos Med Assoc. 2002; 101: 726-728
        • Hou J.W.
        Smith-Magenis syndrome: report of one case.
        Acta Paediatr Taiwan. 2003; 44: 161-164
        • Van Thillo A.
        • Devriendt K.
        • Willekens D.
        Sleep disturbances in Smith Magenis syndrome: treatment with melatonin and beta-adrenergic antagonists.
        Tijdschr Psychiatr. 2010; 52 ([abstract]): 719-723
        • Zhdanova I.
        • Wurtman R.
        • Wagstaff J.
        Effects of low dose melatonin on sleep in children with Angelman syndrome.
        J Pediatr Endocrinol Metab. 1999; 12: 57-67
        • Braam W.
        • Didden R.
        • Smits M.
        • et al.
        Melatonin for chronic insomnia in Angelman syndrome: a randomized placebo-controlled trial.
        J Child Neurol. 2008; 23: 649-654
        • Braam W.
        • Smits M.
        • Didden R.
        • et al.
        Exogenous melatonin for sleep problems in individuals with intellectual disability: a meta-analysis.
        Dev Med Child Neurol. 2009; 51: 340-349